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Abstract
Background Acute leukemias of childhood are a hetero-
geneous group of malignancies characterized by cytoge-
netic abnormalities, such as translocations and changes in
ploidy. These abnormalities may be inﬂuenced by altered
DNA repair and cell cycle control processes.
Methods We examined the association between child-
hood acute lymphoblastic leukemia (ALL) and 32 genes in
DNA repair and cell cycle pathways using a haplotype-
based approach, among 377 childhood ALL cases and 448
controls enrolled during 1995–2002.
Results We found that haplotypes in APEX1, BRCA2,
ERCC2, and RAD51 were signiﬁcantly associated with
total ALL, while haplotypes in NBN and XRCC4, and
CDKN2A were associated with structural and numerical
change subtypes, respectively. In addition, we observed
statistically signiﬁcant interaction between exposure to 3 or
more diagnostic X-rays and haplotypes of XRCC4 on risk
of structural abnormality-positive childhood ALL.
Conclusions These results support a role of altered DNA
repair and cell cycle processes in the risk of childhood
ALL, and show that this genetic susceptibility can differ by
cytogenetic subtype and may be modiﬁed by exposure to
ionizing radiation. To our knowledge, our study is the ﬁrst
to broadly examine the DNA repair and cell cycle path-
ways using a haplotype approach in conjunction with X-ray
exposures in childhood ALL risk. If conﬁrmed, future
studies are needed to identify speciﬁc functional SNPs in
the regions of interest identiﬁed in this analysis.
Keywords Leukemia  Childhood cancer  DNA repair 
Genetic susceptibility
Introduction
Leukemia, a heterogeneous group of hematological
malignancies, is the most common cancer in children.
Nearly all pediatric cases of leukemia are acute in nature,
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(ALL) [1]. ALL is characterized by speciﬁc chromosomal
abnormalities, such as translocations and changes in
ploidy, that may result from unrepaired DNA damage such
as double-strand breaks (DSBs) [2, 3]. The few known risk
factors for childhood leukemia include exposure to ioniz-
ing radiation and some chemotherapeutic agents [4], which
are known to cause cellular DNA damage [5]. Repair of
damage resulting from exposure to such agents is a critical
cellular maintenance function. Therefore, alterations in
innate DNA repair, cell cycle, or genomic maintenance
processes may play a role in leukemia development [6–8].
In addition to altered DNA repair processes, DNA DSBs
can also arise via the inhibition of DNA topoisomerases
[9], or immune-cell speciﬁc processes such as somatic
hypermutation and class-switch recombination [10, 11].
Germline single nucleotide polymorphisms (SNPs) in
genes that control these processes may alter their function,
resulting in the accumulation of DNA damage and chro-
mosomal instability.
Cancers at numerous sites have been linked to SNPs in
speciﬁc DNA repair pathways, including nucleotide exci-
sion repair (NER), mismatch repair (MMR), and DSB repair
and breast cancer [12, 13]. In addition, SNPs in genes that
control cell cycling and checkpoints may determine whether
cellswithsubstantialDNAdamageandinstabilityprogressto
replication or undergo apoptosis [5, 14].
In order to explore the association between germline
genetic variants and ALL, we examined 21 genes in base
excision (BER), nucleotide excision (NER), and DSB
repair pathways, and 11 genes in cell cycle and genomic
maintenance pathways, among 377 childhood ALL cases
and 448 controls from a population-based study of child-
hood leukemia in Northern and Central California. In
addition, while the association between high doses of
ionizing radiation and leukemia is well established [15,
16], the evidence for low dose sources such as diagnostic
X-rays is evolving. As we previously found exposure to
diagnostic X-rays postnatally to be a risk factor for child-
hood leukemia [17], we examined whether the risk of
childhood ALL associated with diagnostic irradiation is
modiﬁed by variants in DNA repair genes.
Materials and methods
Study subjects
The study was conducted among children participating in
the Northern California Childhood Leukemia Study
(NCCLS), an ongoing population-based case–control
study. The study enrollment and recruitment procedures
have been described in detail previously [18]. Brieﬂy, case
children under 15 years of age with incident leukemia were
ascertained within 72 h of diagnosis via a rapid reporting
system established with the diagnosing hospitals. Control
children selected from California birth certiﬁcates were
matched to case children on date of birth, sex, maternal
race, and child’s Hispanic ethnicity (having at least one
parent reporting Hispanic ethnicity). Participation rates
among eligible cases and controls were 87 and 86%,
respectively. Data on potential risk factors were elicited
from an English- or Spanish-speaking parent (usually
the mother) by trained interviewers using a structured
questionnaire.
This study was reviewed and approved by institutional
review committees at the University of California Berke-
ley, the California Department of Public Health, and the
participating hospitals. Written informed consent was
obtained from all parent respondents.
Biospecimen collection and DNA processing
Buccal cytobrush specimens successfully collected at
interview from 95% of participating children were pro-
cessed by heating in the presence of 0.5 N NaOH. Isolated
DNA was later repuriﬁed using an automated DNA
extraction system (AutoGen, Holliston, MA), whole-gen-
ome ampliﬁed using GenomePlex reagents (Rubicon
Genomics, Ann Arbor, MI). When buccal cytobrush DNA
was inadequate (26.6% of subjects), DNA was isolated
from dried bloodspots (DBS) collected at birth and
archived by the Genetic Diseases Screening Program of the
California Department of Public Health. After extraction
(QIAamp 96 DNA Blood Kit, QIAGEN, Germany), these
DNA samples were whole-genome ampliﬁed using REPLI-
g reagents (QIAGEN). Regardless of source, DNA speci-
mens were quantitated using human-speciﬁc Alu-PCR to
conﬁrm a minimum level of ampliﬁable human DNA [19].
We have previously shown that highly multiplexed Gold-
enGate genotyping (Illumina, San Diego, CA) of whole-
genome ampliﬁed buccal cell DNA yields genotypes that
are highly concordant with those from genomic DNA from
peripheral blood [20]. We genotyped DNA specimens
from both buccal cells and DBS for 9 subjects; genotype
concordance between paired samples was 98.9%.
Selection of variants
This analysis included SNPs in 32 genes involved in DNA
repair, cell cycle and genomic stability processes. These
genes were selected after consensus review by our inves-
tigative team after review of the literature. These include
base excision repair (APEX1, MUTYH, UNG2, XRCC1),
nucleotide excision repair (ERCC2), double-strand break,
nonhomologous end-joining (LIG4, PRKDC, XRCC4,
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123XRCC5, XRCC6), double-strand break, homologous
recombination (BRCA1, BRCA2, MRE11, NBN, RAD50,
RAD51, RAD54B, RAD54L, XRCC2, XRCC3),d i r e c t
reversal of damage (MGMT), cell cycle (TP53, TP53BP1,
CCND1, CDKN2A (p16), CDKN2B (p15)), topoisome-
rases (T O P 1 ,T O P 2 A ,T O P 2 B ) ,and recombination of
immunoglobulin and T-cell receptor genes (AICDA,
RAG1, RAG2).
Using HaploView [21] in conjunction with SNP data
from the 30 Caucasian trios in the HapMap project
(Release 19, Build 34, www.hapmap.org) and the 23 His-
panics in the SNP500Cancer project (www.snp500cancer.
nci.nih.gov), we selected haplotype-tagging SNPs (htSNPs)
that captured at least 80% of the haplotype diversity for
common haplotypes ([5% frequency) in either the Cau-
casian or Hispanic populations [22]. As Hispanics are a
recently admixed ethnic group and comprise 42% of our
study population, we placed special emphasis on capturing
haplotype structures in this population. To maximize cap-
ture of potential regulatory regions, we included 10 kb
stretches both up- and downstream from the gene bound-
aries reported in the UCSC Genome Browser. In addition,
we identiﬁed non-synonymous SNPs within these genes.
Finally, a set of ancestry informative markers (AIMs) was
included for SNP genotyping; these had been previously
identiﬁed to distinguish Amerindian, African, and Euro-
pean populations [23], three populations that make up the
genetic ancestry of US Hispanics.
Genotyping
Although the study recruitment was originally of an indi-
vidually matched design, we performed a frequency-mat-
ched analysis by including all subjects with available
biospecimens from 1995 through 2002. Accordingly, we
genotyped whole-genome ampliﬁed DNAs of 385 available
ALL cases and 456 available controls enrolled from 1995
to 2002 using a custom Illumina GoldenGate assay panel
with a GenCall threshold of 0.25. Fifty-nine duplicate
samples that were processed in the same manner and
genotyped on the same plate showed[99% concordance in
genotype. For these duplicates, the sample with the higher
SNP call rate within each pair was included in the ﬁnal
data. SNPs were excluded if the call rate was less than 90%
(29 SNPs), had minor allele frequencies less than 5% in
both Hispanics and non-Hispanics (6 SNPs), or failed
Hardy–Weinberg equilibrium (p\0.01) in both Hispanic
and non-Hispanic controls (1 SNP). After applying these
data quality thresholds, data for 238 SNPs in the 32
selected genes were available for 377 ALL cases and 448
controls. A total of 80 AIMs were successfully typed in
these subjects.
Cytogenetic characterization
The cytogenetic classiﬁcation methods used in this analysis
have been described in detail elsewhere [24]. Brieﬂy,
pretreatment diagnostic karyotype and ﬂuorescence in situ
hybridization (FISH) data were abstracted from leukemia
patient records shortly after diagnosis. Additional FISH
analyses were conducted at the University of California,
Berkeley, to identify ETV6-RUNX1 [t(12; 21)] transloca-
tions and hyperdiploidy when not done at hospitals. As
shown in Table 1, the presence of any structural or
numerical change was common among the NCCLS case
population. The most frequent structural abnormality,
t(12;21), was more common among non-Hispanics than
Hispanics. Among cases with a numerical chromosomal
change of any kind, high hyperdiploidy ([51 chromo-
somes) was most commonly observed. Because of the low
prevalence for most other individual structural and numeric
changes, cytogenetic subgroup analyses were limited to
t(12;21), high hyperdiploidy, and the broader categories
‘‘any structural change’’ and ‘‘any numerical change’’.
Diagnostic X-ray exposure assessment
Information on child’s X-rays received prior to the date of
diagnosis for cases or corresponding reference date for
matched controls (hereafter called ‘‘postnatal X-rays’’),
was collected during the in-person interview as described
previously [17]. All postnatal diagnostic X-ray exposures,
with the exception of dental X-rays, were reported by the
following broadly deﬁned regions of the body: chest, skull,
broken bone, and ‘‘other’’. Respondents also reported the
number of postnatal X-rays received and the age at ﬁrst
X-ray. Postnatal X-ray exposure information was available
for 746 (90.4%) of the genotyped study participants. In our
genotyped study sample, having 3? x-diagnostic X-rays
postnatally was associated with a signiﬁcantly increased
risk of childhood ALL (OR = 2.49, 95% CI 1.55–3.98),
similar to our previous report on a larger sample size [25].
Statistical analysis
Based on the AIMs, individual estimates of genetic
ancestry, i.e., percent contribution of each of the three
ancestral populations per person, were obtained from
maximum likelihood estimation as described previously
[26]. Using the confounding relative risk (CRR) [27], we
found no evidence of major confounding by estimated
genetic ancestry ([10%) over and above adjustment for
self-identiﬁed race and ethnicity. As a result, our analysis
proceeded with stratiﬁcation by or adjustment for self-
identiﬁed race and ethnicity.
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tested for potential interactions of individual SNPs with
Hispanic ethnicity using the likelihood ratio test at the 0.05
signiﬁcance level. We used unconditional logistic regres-
sion to estimate odds ratios (ORs) for the log-additive
associations of individual SNPs, both overall and by
cytogenetic subtype, after adjusting for age at diagnosis,
sex, and child’s race, plus child’s Hispanic ethnicity in
analyses combining Hispanics and non-Hispanics.
For haplotype analyses, we applied a sliding window
approach for each gene, as implemented in the haplo.stats
package for R [28], using window sizes of 2–5 SNPs. This
approach examines sub-haplotypes using the full set of
SNP data, with differently sized ‘‘windows’’ of adjacent
alleles. This is an effective means of combining multi-
locus data for Hispanics and non-Hispanics, as it is
agnostic to differences in haplotype structure, provided no
individual SNPs for a given gene show signiﬁcant effect
heterogeneity by Hispanic ethnicity (pinteraction B 0.05). If
none of the individual SNPs in a given gene showed such
heterogeneity, data for both ethnic groups were combined
for sliding window analyses; for genes in which signiﬁcant
single-SNP heterogeneity by ethnicity existed, the sliding
window analysis for that gene was conducted separately
for Hispanics and non-Hispanics. We utilized GrASP, a
graphical tool [29], to display and visualize sliding win-
dow results. We used haplotype trend regression [30]t o
estimate the magnitude of effect associated with risk
haplotypes of the windows with the smallest global
p values.
Assessment of potential interactions with exposure to
ionizing radiation was limited to single SNPs or haplotypes
with signiﬁcant main effects; the signiﬁcance of these was
assessed in logistic regression models using the likelihood
ratio test. The number of postnatal X-rays received by the
child was modeled as a dichotomous variable (0–2 vs. 3?
X-rays). Postnatal X-rays that occurred less than a year
prior to the date of diagnosis for cases or corresponding
reference date for controls were excluded from analysis.
Maternal X-rays received during the year prior to con-
ception and during pregnancy were excluded from analysis
due to low prevalence of exposure in the study population.
Results
Characteristics of the study population are presented in
Table 1 stratiﬁed by Hispanic ethnicity. Cases and controls
were similar with respect to age, sex, and maternal race.
Of the 32 genes examined, 6 included one or more
individual SNPs with effects that differed signiﬁcantly
between Hispanics and non-Hispanics (APEX1, BRCA1,
BRCA2, MGMT, RAD51, and RAG2). Accordingly, hap-
lotype sliding window analyses for these 6 genes were
stratiﬁed by Hispanic ethnicity, while those for the other 26
genes were conducted with both ethnic groups combined.
Table 1 Demographic and cytogenetic characteristics of Hispanic and Non-Hispanic children, the Northern California Childhood Leukemia
Study, 1995–2002
Non-Hispanic Hispanic
Case (n = 221) Control (n = 269) p Value Case (n = 156) Control (n = 179) p Value
n (%) n (%) n (%) n (%)
Male gender, n (%) 123 (55.7) 150 (55.8) 0.9 77 (49.4) 87 (48.6) 0.6
Age, years (SE) 5.6 (3.4) 5.5 (3.6) 0.7 5.5 (3.4) 5.4 (3.5) 0.8
Maternal race, n (%)
White 162 (73.3) 198 (73.6) 0.5 52 (33.3) 57 (31.8) 0.4
Black 13 (5.9) 14 (5.2) 2 (1.3) 2 (1.1)
Native american 1 (0.4) 1 (0.4) 6 (3.8) 7 (3.9)
Asian/paciﬁc islander 25 (11.3) 33 (12.2) 0 (0) 2 (1.1)
Mixed/other 20 (9.1) 23 (8.6) 96 (61.5) 111 (62.0)
Post-natal X-rays, n (%)
a
0–2 173 (87.4) 233 (93.2) 0.04 112 (81.8) 154 (95.7) \0.01
3? 25 (12.6) 17 (6.8) 25 (18.2) 7 (4.3)
ALL Cytogenetic characteristics
Any structural change 106 (48.0) N/A 63 (40.4) N/A
ETV6-RUNX1 [t(12;21)] 43 (19.5) N/A 19 (12.2) N/A
Any numerical ploidy change 119 (53.8) N/A 90 (57.7) N/A
High hyperdiploidy ([51 chromosomes) 95 (40) N/A 51 (56) N/A
a x-ray exposure information available for 746 (90.4%) of study subjects
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signiﬁcant (p B 0.05) haplotype effects that persisted
through increasingly larger windows are presented in the
Supplemental Material. Haplotype trend regression results
estimating the magnitudes of effect for haplotypes with the
lowest multi-SNP p value in sliding window analyses are
shown in Table 2 for total ALL, and in Table 3 for speciﬁc
ALL subtypes.
For total ALL, among both ethnicities combined,
ERCC2 showed a signiﬁcant haplotype association that
persisted through progressively larger SNP windows, with
haplotype G-A-A showing a signiﬁcantly reduced risk
(OR = 0.59, p = 0.018). Among Hispanics, haplotypes
A–A-A and A-G-A of RAD51 were signiﬁcantly associated
with increased risks of total ALL (OR = 1.55 and
p = 0.05, OR = 1.51 and p = 0.04, respectively). Among
non-Hispanics, APEX1 and BRCA2 showed signiﬁcant
haplotype associations with total ALL: haplotype A–A of
APEX1 was signiﬁcantly associated with an increased risk
(OR = 1.90, p = 0.003), and haplotype G-A of BRCA2
was signiﬁcantly associated with an increased risk (OR =
1.77 p = 0.02).
We performed haplotype analyses for speciﬁc ALL
subtypes for genes with nominally signiﬁcant associations
among both ethnicities combined (Table 3). Two genes
(NBN and XRCC4) showed signiﬁcant associations with
t(12;21) translocation-positive childhood ALL (global
p B 0.05). For NBN, haplotype A–A-G-A-G was border-
line signiﬁcantly associated with a reduced risk (OR =
0.55, p = 0.057). For XRCC4, haplotypes C-G-G-G-A and
C-G-A-G-A were signiﬁcantly associated with reduced risk
(OR = 0.39 and p = 0.039, OR = 0.56 and p = 0.05,
respectively). XRCC4 was also signiﬁcantly associated
with childhood ALL with any structural abnormalities:
haplotypes G-A-G and G–G-G were both signiﬁcantly
associated with a reduced risk (OR = 0.60 and p = 0.006,
and OR = 0.55 and p = 0.012, respectively). Of particular
interest, the two 3-SNP risk haplotypes of XRCC4 are part
of the two signiﬁcant 5-SNP risk haplotypes associated
with t(12;21) translocation-positive childhood ALL, and
have a similar effect.
For high-hyperdiploid-positive childhood ALL, and
more broadly for childhood ALL with any numerical ploidy
changes, there were signiﬁcant haplotype associations with
Table 2 Signiﬁcant haplotype
trend regression results (global
p B0.05), for total childhood
ALL, by ethnicity, NCCLS,
1995–2002
a Haplotype frequency among
the 448 controls. All case
subtypes were compared to this
control group
b ORs were adjusted for age,
sex, and race (plus Hispanic
ethnicity in analyses of both
ethnicities combined) using
unconditional logistic
regression
c Global p values for haplotype
trend regression in other ethnic
group: APEX1 haplotype in
Hispanics, p = 0.09; BRCA2
haplotype in Hispanics,
p = 0.95; RAD51 haplotype in
non-Hispanics, p = 0.32
d Haplotypes with frequencies
less than 1% were grouped
together for analysis
Genes/haplotypes Haplotype
frequency
a (%)
OR (95% CI)
b p Value Global p Value
c
ERCC2—both ethnicities
rs3916874, rs238416, rs171140
GGA 37.0 Reference N/A 0.02
CGA 12.0 0.96 (0.60, 1.52) 0.853
CGC 9.0 1.11 (0.80, 1.53) 0.537
GAA 4.0 0.59 (0.38, 0.91) 0.018
GAC 36.0 1.65 (0.92, 2.95) 0.094
GGC 2.0 0.91 (0.72, 1.16) 0.461
APEX1-non-Hispanics
rs11160711, rs3120073
GA 46.0 Reference N/A 0.004
AA 29.0 1.90 (1.25, 2.89) 0.003
GG 25.0 1.58 (0.94, 2.67) 0.090
BRCA2—non-Hispanics
rs4942448, rs9943876
GG 71.0 Reference N/A 0.006
GA 8.0 1.77 (1.10, 2.85) 0.020
AA 21.0 0.73 (0.52, 1.05) 0.090
RAD51—Hispanics
rs2304579, rs7177265, rs2304580
AAG 46.0 Reference N/A 0.03
AAA 21.0 1.55 (1.01, 2.42) 0.050
AGA 24.0 1.51 (1.01, 2.26) 0.040
GAA 8.0 0.58 (0.27, 1.25) 0.170
Rare haplotypes
d 1.0 1.83 (0.40, 8.27) 0.430
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cantly associated with a reduced risk of hyperdiploid-
positive disease (OR = 0.30, p = 0.002), while risk
reduction associated with the A–A haplotype was margin-
ally signiﬁcant (OR = 0.73, p = 0.09). Looking more
broadly at childhood ALL with any numerical changes,
these same haplotypes showed signiﬁcant associations
(OR = 0.44 and p = 0.01, OR = 0.67 and p = 0.008,
respectively).
In testing gene-environment interactions, we investigated
interactions of postnatal X-ray exposures (0–2 vs. 3 or more)
with those haplotypes that showed nominally signiﬁcant
main effects in both ethnicities combined, both for total ALL
and by major ALL subtype. At the p B 0.05 level, we found
the main effect of the G–G-G haplotype of XRCC4 with
ALL with any structural abnormalities was signiﬁcantly
modiﬁed by number of postnatal X-rays (p = 0.027).
No such interactions were observed for NBN or ERCC2.
Table 3 Signiﬁcant haplotype
trend regression results (global
p B 0.05), by major childhood
ALL subtype, both ethnicities
combined, NCCLS, 1995–2002
a Haplotype frequency among
the 448 controls. All case
subtypes were compared to this
control group
b ORs were adjusted for age,
sex, Hispanic ethnicity and race
using unconditional logistic
regression
c Haplotypes less with
frequencies less than 5% were
grouped together for analysis
Genes/haplotypes Haplotype frequency
a (%) OR (95% CI)
b p Value Global p Value
T12;21 (n = 62 cases)
NBN
rs12680687, rs6470522, rs7840099, rs1805812, rs709816
GCGGA 40 Reference N/A 0.04
AAGAA 17 0.55 (0.30, 1.01) 0.057
AAGAG 6 1.23 (0.63, 2.42) 0.539
GCAGA 16 0.64 (0.35, 1.17) 0.147
GCGAA 8 0.52 (0.22, 1.22) 0.134
Rare haplotypes
c 13 0.38 (0.16, 0.88) 0.025
XRCC4
rs7711825, rs1193695, rs301276, rs301287, rs3777018
CAGGA 34 Reference N/A 0.006
AAGGA 4 1.85 (0.87, 3.94) 0.109
AAGGG 6 0.62 (0.24, 1.64) 0.339
CGAGA 21 0.56 (0.31, 1.00) 0.050
CGGAA 6 0.91 (0.40, 2.09) 0.821
CGGGA 11 0.39 (0.16, 0.95) 0.039
Rare haplotypes
c 15 0.35 (0.16, 0.74) 0.007
Any structural change (n = 169 cases)
XRCC4
rs1193695, rs301276, rs301287
AGG 47 Reference N/A 0.01
AGA 6 0.65 (0.35, 1.20) 0.170
GAG 23 0.60 (0.42, 0.86) 0.006
GGA 12 0.83 (0.56, 1.24) 0.365
GGG 13 0.55 (0.35, 0.88) 0.012
Hyperdiploidy (n = 163 cases)
CDKN2A
rs3731257, rs2518719
GA 60 Reference N/A \0.001
AA 29 0.73 (0.51, 1.05) 0.090
GG 11 0.30 (0.14, 0.64) 0.002
Any numerical ploidy change (n = 209 cases)
CDKN2A
rs3731257, rs2518719
GA 63 Reference N/A \0.001
AA 28 0.67 (0.50, 0.90) 0.008
GG 8 0.44 (0.26, 0.73) 0.001
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In this study, we utilized a haplotype-tagging approach to
examine the role of variants in genes involved in DNA
repair and genomic maintenance in risk of childhood ALL.
We found signiﬁcant haplotype associations with total
ALL for ERCC2, RAD51, APEX1, and BRCA2; and with
speciﬁc ALL subtypes for NBN, XRCC4, and CDKN2A.
In addition, we observed signiﬁcant gene-environment
interactions between XRCC4 variants and exposure to
diagnostic X-rays modulating the risk of structural abnor-
mality-positive childhood ALL. Our results provide strong
support for a role of the DNA repair and cell cycle control
pathways in risk of childhood ALL.
APEX1 encodes the major apurinic/apyrimidinic (AP)
endonuclease in human cells. AP sites occur frequently in
DNA as a result of spontaneous hydrolysis, damaging
agents, or glycosylases that remove speciﬁc abnormal
bases; therefore, APEX1 plays an important role in base
excision repair. Gene expression analyses of APEX1 have
shown high levels of expression in many different types of
tumors, including osteosarcoma, ovarian, and digestive
cancers ([31] Endunuclease, [32]). The two SNPs involved
in the observed APEX1 risk haplotype were borderline
signiﬁcantly associated with total childhood ALL after
adjustment for the false discovery rate (pFDR = 0.06 for
both) [33]. Of these, rs3120073, whose variant allele was
associated with decreased risk ALL among both ethnicities
combined,islocated6.5 kbupstreamofAPEX1,inintron6of
OSGEP,aprobableendopeptidase.AnalysisofHapMapCEU
population data shows that this SNP is not in strong linkage
disequilibrium (r
2[0.80) with any nearby SNPs (\10 kbp),
thoughHapMapgenotypingdataforthisvariantwasavailable
for less than 50% of the CEU population. The other involved
SNP,rs11160711,whosevariantallelewasassociatedwithan
increased risk of total childhood ALL among non-Hispanics,
is10kbupstreamofAPEX1.NeitherSNPhasknownfunction.
Additional studies are warranted to replicate these ﬁndings
and identify functional variants that may be in strong linkage
disequilibrium with these SNPs.
The ERCC2 gene product is involved in nucleotide
excision repair. Defects in this gene can cause rare genetic
syndromes, including the cancer-prone syndrome xero-
derma pigmentosum complementation group D, which
necessitates protection from ultraviolet light [34]. We
found a signiﬁcant haplotype association for this gene with
total childhood ALL risk. Separately, the BRCA2 gene
product, a tumor suppressor, interacts with the RAD51 gene
product, a recombinase, to effect homologous repair of
double-strand breaks [35]. We observed signiﬁcant haplo-
type associations for BRCA2 and RAD51, albeit in different
ethnic groups. These results must be conﬁrmed, but support
a role for DSB repair pathways in risk of childhood ALL.
The X-ray repair cross-complementing protein encoded
by XRCC4 is involved in nonhomologous end-joining
repair of double-strand DNA breaks and the completion of
V(D)J recombination events [36, 37]. In addition to the
signiﬁcant haplotype associations with this gene for ALL
with any structural changes, we observed a signiﬁcant
interaction between the XRCC4 risk haplotype and expo-
sure to postnatal X-rays on risk of the same disease sub-
type. These effects appear to be driven largely by intronic
SNP rs1193695, which showed nominally signiﬁcant main
effects and interactions with postnatal X-ray exposure for
both total ALL as well as ALL subtypes deﬁned by any
structural changes and any numerical changes. Our results
provide compelling support for a role of the nonhomolo-
gous end-joining repair pathway in risk of ALL, particu-
larly ALL with structural abnormalities, both alone and in
conjunction with exposure to ionizing radiation.
Other genes showed signiﬁcant subtype-speciﬁc haplo-
type associations as well. Haplotypes of NBN were asso-
ciated with t(12;21) positive childhood ALL. NBN is part
of the MRE11/RAD50 DSB repair complex, involved in
homologous DSB repair. Mutations in this gene can lead to
Nijmegen breakage syndrome, a chromosomal instability
syndrome that predisposes to cancer, among other diseases
[38]. These results for NBN did not extend more broadly to
ALL with any structural changes.
In contrast, haplotypes of CDKN2A were associated
with both hyperdiploid ALL and ALL with any numerical
ploidy changes. CDKN2A is a cell cycle control gene
recognized as a tumor suppressor for its role in stabilizing
p53. A study of secondary hits from a genome-wide
association study found CDKN2A SNP rs3731217, which
was not included for genotyping in our study, to be asso-
ciated with childhood ALL, speciﬁcally B-cell precursor
disease [39]. Our results support these previous ﬁndings for
a role of CDKN2A in childhood ALL risk, and suggest that
further studies should examine effects by ploidy.
Few previous candidate gene studies have investigated
the main effects of DNA repair pathway gene variants in
the etiology of childhood ALL, and those that have were
typically of smaller sample size (less than 200 cases) and
focused on analyses of individual SNPs with putative
function (i.e., inducing amino acid changes or located in
potential regulatory regions). One study reported signiﬁ-
cant association of a promoter variant of CDKN2A with
childhood pre-B-cell ALL [40], while another reported an
association of a functional ERCC1 variant with total
childhood ALL ([41] 2006). Other studies have found
signiﬁcant main effects of functional SNPs in XRCC1 [42,
43], and a signiﬁcant haplotype combining three of these
XRCC1 functional variants of XRCC1 has also been
observed [42]. In our study, we did not observe a signiﬁ-
cant haplotype association for XRCC1 or ERCC1 though
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tencies between our study and previous candidate gene
studies may be attributable to a number of factors,
including the differences in approach (haplotype vs. indi-
vidual SNP), population and/or allele frequency differences
and sample size differences that impact power to detect
effects, as well as chance.
To our knowledge, this study is the ﬁrst to examine the
joint effects of genes in the DNA repair and cell cycle
control pathways with ionizing radiation on risk of child-
hood ALL using a haplotype approach. We focused on
interactions involving haplotypes with signiﬁcant main
effects, as the biological basis is unclear for interactions
involving signiﬁcant subgroup variation in exposure–
disease associations with no main effects when subgroups
are combined [44]. We also limited our investigation of
potential interactions to those haplotypes with signiﬁcant
main effects in both Hispanics and non-Hispanics com-
bined, as the sizes of the individual ethnic groups were
considered too small to permit adequately powered exam-
inations of interactions. A previous study focusing on
single SNPs using a case-only interaction study design
reported a suggestive interaction between an APEX1 SNP
and postnatal X-ray exposure [45]. Per our a priori analysis
plan, we did not examine APEX1 haplotype interactions
since this gene showed signiﬁcant main effects in only non-
Hispanics. In this regard, we recognize that our total sample
size (343 cases, 406 controls with both genetic and exposure
data)maybeinsufﬁcienttoobservemodestinteractioneffects
with adequate statistical power. In addition, although the role
of post-natal diagnostic X-rays in childhood ALL risk is not
entirely clear [16], we previously found exposure to postnatal
X-rays to be signiﬁcantly associated with childhood ALL
(OR = 1.85, 95%CI: 1.22–2.79 for 3? vs. 0–2 X-rays) in a
larger sample size (n = 711cases),ofwhichthecurrentstudy
population is a subset [17]. However, these measures are
derived from maternal reports of the child’s exposures and
exposureperiodsandarepotentiallysubjecttoreportingerrors.
Further studies with improved measures of ionizing radiation
exposure, perhaps via review of medical records, as well as
data on other potential DNA damaging exposures and larger
sample sizes, are needed to conﬁrm the associations observed.
One of the strengths of our study is the inclusion of U.S.
Hispanics, an understudied population whose childhood
leukemia incidence rates are the highest reported in Cali-
fornia [46]. We selected SNPs in a manner to maximize
capture of genetic variation in Hispanics, and examined
Hispanics separately from non-Hispanics where there was
signiﬁcant heterogeneity in between-group effects of indi-
vidual SNPs. Although this approach may have limited our
ability to detect associations in the population as a whole,
we believe it was necessary given that genetic suscepti-
bility and/or patterns of linkage disequilibrium may be
different in Hispanics versus non-Hispanics due to the
Hispanic population’s relatively recent genetic admixture
[23]. Results that differ between Hispanics and non-His-
panics may be due to differences in allele frequency and/or
haplotype structure, or may reﬂect underlying differences
in exposures that modulate the effects of genes. Regardless,
if the results are not spurious, they represent potential risk
loci, and we present them in either or both ethnic groups
for replication and further followup. A ﬁnal point is that the
limited size of certain racial/ethnic sub-populations among
non-Hispanics precluded further stratiﬁcation of this group;
therefore, heterogeneity among non-Hispanics might have
obscured results.
In gauging these results, consideration must be given to
several factors. First, despite this study’s relatively large
sample size compared to those of most previous candidate
gene studies, the presence of genetic heterogeneity due to
the ethnic and racial diversity of the California population
may have inﬂuenced our ability to detect associations.
However, in this study population, we found no evidence
of strong confounding due to estimated genetic ancestry,
minimizing concerns about the impact of population
stratiﬁcation on the results. In addition, as noted above, our
ﬁndings for CDKN2A conﬁrm those from analyses of
secondary hits from a recent genome-wide association
study [39]. However, associations identiﬁed in our study
for other genes, including APEX1, ERCC2, and others,
were not observed in the primary or secondary hits of the
large genome-wide studies conducted to date [39, 47, 48].
This may be due to stringent multiple testing adjustment (at
the p B 1 9 10
-7 level) to account for the large number of
individual variants investigated in the genome-wide stud-
ies. In contrast to the agnostic approach to discovery used
in genome-wide studies, our study focused on relatively
few genes representing key elements of the DNA repair
and cell cycle control pathways. Other DNA repair genes
not included in our study may also be associated with
disease;weareunable tocommentonthese.Weconcedethat
results of our study may be due to chance, and therefore must
be replicated. However, the haplotype-tagging approach we
adopted maximizes capture of total variation within each
candidategeneandthehaplotypeanalysisincreasesstatistical
power to detect associations over analyses of individual
variants. Finally, differences in genetic risk factors by cyto-
genetic subtypes may be obscured in studies that do not
stratify analyses by these subtypes.
In summary, our results indicate that elements of the
DNA repair and cell cycle pathways are likely to be
associated with childhood ALL, and that some of these
elements may interact with ionizing radiation exposures to
modulate risk. The associations and interactions identiﬁed
should be considered targets for further analysis in studies
with larger sample sizes, high quality environmental
1728 Cancer Causes Control (2011) 22:1721–1730
123exposure data, and ﬁner coverage of SNPs in the identiﬁed
associated regions.
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